Table 1.

Participants’ demographic, anthropometric, PUFA, and clinical characteristics at baseline and follow-up.

		Baseline	6-month follow-up
Demographic details
Age in years, mean ± SD		18 ± 4	—
BMI in kg/m2, mean ± SD		24.20 ± 5.43	—
Gender, n (%)	Female	81 (63%)	—
	Male	47 (37%)	—
Biological and clinical measures
Erythrocyte membrane fatty acid levels in %, mean ± SD	Total omega-3 fatty acids	11.94 ± 1.68	13.34 ± 4.40
	Total omega-6 fatty acids	35.56 ± 1.73	31.47 ± 4.12
Positive symptom severity (PSS) score, mean ± SD		25 ± 22	14 ± 15
Social and Occupational Functional Assessment Scale score, mean ± SD		55 ± 10	67 ± 15
Brief Assessment of Cognition in Schizophrenia- composite score, mean ± SD		25 ± 22	51 ± 13

SD Standard deviation.